Patients who undergo continuous hemofiltration
Conditions
Interventions
None listed
Sponsors
Department of Intensive Care Medicine, Sapporo Medical University School of Medicine
Otsuka Pharmaceutical Factory, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with sepsis or acute kidney injury (KDIGO stage 1 or higher) (2) Patients aged 18 years or older on the date of informed consent (3) Patients who are able to provide written informed consent or whose legally acceptable representative is able to provide written informed consent
Exclusion criteria
Exclusion criteria: (1) Patients with liver failure (2) Patients who need other blood purification therapy within 4 hours after the continuous hemofiltration is started (3) Patients who need to change the conditions of continuous hemofiltration within 4 hours after the continuous hemofiltration is started (4) Patients who need enteral nutrition or parenteral nutrition containing amino acids within 4 hours after the continuous hemofiltration is started (5) Patients who are determined ineligible by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amino acid concentration in the blood Amino acid loss in the filtrate | — |
Secondary
| Measure | Time frame |
|---|---|
| - Thirty-nine amino acid concentrations in the blood - Thirty-nine amino acid concentrations in the filtrate - Urine volume | — |
Countries
Japan
Contacts
Public ContactHiroomi Tatsumi
Sapporo Medical University School of Medicine Department of Intensive Care Medicine
Outcome results
None listed